Journal ArticleOPEN ACCESS

HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19

Science Immunology (2020) 5(47)
DOI: 10.1126/sciimmunol.abc5367
88Citations
Citations of this article
215Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

JAK kinase inhibitors are being investigated as a way of managing cytokine storm in patients with severe COVID-19.

Cite

CITATION STYLE

APA

Spinelli, F. R., Conti, F., & Gadina, M. (2020). HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19. Science Immunology, 5(47). https://doi.org/10.1126/sciimmunol.abc5367

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free